Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis. (Q34471813)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis. |
scientific article |
Statements
Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis (English)
Miriam Merad
Rikhia Chakraborty
Oliver A Hampton
Xiaoyun Shen
Stephen J Simko
Albert Shih
Harshal Abhyankar
Karen Phaik Har Lim
Kyle R Covington
Lisa Trevino
Ninad Dewal
Harshavardhan Doddapaneni
Jianhong Hu
M John Hicks
Diana L Bonilla
Karen C Dwyer
Marie-Luise Berres
Poulikos I Poulikakos
David A Wheeler
Carl E Allen
D Williams Parsons
8 September 2014
1 reference
1 reference
1 reference